Colorectal cancer (CRC) is the third most common cancer in men and women and has the second highest mortality rate worldwide. Several CRC cases are early identified thanks to the numerous screening programs in many countries but also many cases are found in patients presenting with symptoms in primary health care. The laboratory tests for […]
READ MORE "March is the National Colorectal Cancer Awareness Month"
Sentinel Diagnostics is supporting World Cancer Day with a Screening Program. World Cancer Day is a global event to raise awareness for prevention in order to diagnose cancer at its early stage and, as a diagnostics company, we know our role is crucial in guaranteeing fast and smart results. For this reason, we would like […]
READ MORE "Report 2020 – CRC Screening Program in the Netherlands"
The demand of medium-large companies to use the EcoVadis methodology is increasing. This instrument certifies their sustainability standards at an international level (Global Reporting Initiative, United Nations Global Compact, ISO 26000). The supervisor is a scientific committee of RSI and supplies chain experts, who ensure impartial and reliable assessments. In 2021, Sentinel Diagnostics joined and […]
READ MORE "EcoVadis Certification for Sentinel Diagnostics"
Sentinel Diagnostics was chosen to be on the cover of the Magazine MD Tech Review for the Special “In Vitro Diagnostics”, Europe Edition. We are honored to be in the “Top 10 In Vitro Diagnostic Solution Companies in Europe – 2021” To help companies navigate through the best-of-breed in vitro diagnostic solution providers, @MD Tech […]
READ MORE "“Top 10 IVD Solution Companies in Europe – 2021”"
An overview of variants and mutations to give us an update on the SARS-CoV-2 VOC* and VOI** as classified by WHO. How often does SARS-CoV-2 mutate? As any virus, it is likely to change or mutate to adapt to the environmental pressure as it infects people. There are several variants that are now spreading, some proving […]
READ MORE "How Many Covids?"
Since the beginning of the COVID-19 pandemic, Sentinel Diagnostics has been working constantly to provide high-quality diagnostic tests, based on patented STAT-NAT® technology, for the detection of SARS-CoV-2 virus. We are constantly monitoring the effectiveness of our NAT tests for the detection of COVID-19 by verifying that variant-defining mutant loci do not fall within primers/probes […]
READ MORE "Sentinel Diagnostics’ kits developed for SARS-CoV-2 detection are not affected by Omicron (B.1.1.529) variants"
Sentinel Diagnostics is constantly committed to supporting the COVID-19 pandemic management. Maria Avelia De Lorenzis, Marketing Leader at Sentinel Diagnostics, was on the stage of the fair “MEDICA 2021” to discuss about the evolution of Covid-19, the future possible scenarios and the challenges that diagnostic labs could face in the next months. Discover how Sentinel […]
READ MORE "Covid-19 from Pandemic to Endemic"
Sentinel Diagnostics’ success is the result of ongoing investments to improve the development and manufacturing stages of our diagnostic devices, which are used to perform diagnostic test around the world. Here the translation of the recent article, published in the Italian newspaper, Corriere della Sera, on July 20th 2021, to retrace the results achieved and […]
READ MORE "Set up a new diagnostic hub in Milan: Sentinel Diagnostics’ project to compete in the diagnostic devices market"
Sentinel Diagnostics (Sentinel CH S.p.A.) is pleased to announce that on June 18th has signed an agreement with BE Biotech Srl to acquire the rights to manufacture and distribute the G6PDH Products. The two companies has defined a transition plan to ensure the continuity and quality of the service offered by BE Biotech Srl and […]
READ MORE "SENTINEL DIAGNOSTICS TO ACQUIRE G6PDH PRODUCTS’ MANUFACTURING AND DISTRIBUTION RIGHTS FROM BE BIOTECH Srl"
“Looking beyond the COVID-19 pandemic”, a round table with Dr. Fulvio Ferrara and Dr. Fabio Rota to speech about the progress and evolution of the Pandemic. Sentinel Diagnostics is honored to join Dr. Fulvio Rota (Head of Department of Laboratory Medicine, Pathology and Molecular Genetics, and Cytogenetics at Italian Diagnostic Center – CDI) and Dr. […]
READ MORE "“Looking beyond the COVID-19 pandemic”"